Honglong Wei

536 total citations
12 papers, 422 citations indexed

About

Honglong Wei is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Honglong Wei has authored 12 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cancer Research, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Honglong Wei's work include Endoplasmic Reticulum Stress and Disease (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers) and Protease and Inhibitor Mechanisms (2 papers). Honglong Wei is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers) and Protease and Inhibitor Mechanisms (2 papers). Honglong Wei collaborates with scholars based in China and New Zealand. Honglong Wei's co-authors include Peng Xiu, Jingtao Zhong, Fuhai Wang, Jie Li, Xueying Sun, Tao Li, Yong Wang, Zongzhen Xu, Feng Liu and Xiaofeng Dong and has published in prestigious journals such as Scientific Reports, Chemical Engineering Journal and Cell Death and Disease.

In The Last Decade

Honglong Wei

12 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Honglong Wei China 11 188 133 104 77 60 12 422
Jingtao Zhong China 14 255 1.4× 137 1.0× 139 1.3× 140 1.8× 119 2.0× 32 590
Jae Woo Jung South Korea 14 255 1.4× 72 0.5× 84 0.8× 97 1.3× 38 0.6× 31 453
Sabrina Priam France 7 190 1.0× 46 0.3× 65 0.6× 72 0.9× 70 1.2× 13 458
Jin Gong China 16 306 1.6× 60 0.5× 127 1.2× 121 1.6× 86 1.4× 41 587
Jung Hwa Lim South Korea 13 264 1.4× 42 0.3× 109 1.0× 104 1.4× 53 0.9× 27 452
Sarani Ghoshal United States 10 201 1.1× 60 0.5× 117 1.1× 115 1.5× 120 2.0× 15 529
Tong Huang China 12 236 1.3× 25 0.2× 107 1.0× 54 0.7× 84 1.4× 26 485

Countries citing papers authored by Honglong Wei

Since Specialization
Citations

This map shows the geographic impact of Honglong Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Honglong Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Honglong Wei more than expected).

Fields of papers citing papers by Honglong Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Honglong Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Honglong Wei. The network helps show where Honglong Wei may publish in the future.

Co-authorship network of co-authors of Honglong Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Honglong Wei. A scholar is included among the top collaborators of Honglong Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Honglong Wei. Honglong Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Ma, Qingjun, et al.. (2024). Rare primary squamous cell carcinoma of the intrahepatic bile duct: A case report and review of literature. World Journal of Clinical Oncology. 15(7). 936–944. 1 indexed citations
2.
Dong, Fenglin, et al.. (2023). Exosomal circTGFBR2 promotes hepatocellular carcinoma progression via enhancing ATG5 mediated protective autophagy. Cell Death and Disease. 14(7). 451–451. 23 indexed citations
3.
Wang, Wentao, Jingtao Zhong, Qi Wang, et al.. (2021). The clinical significance of microvascular invasion in the surgical planning and postoperative sequential treatment in hepatocellular carcinoma. Scientific Reports. 11(1). 2415–2415. 53 indexed citations
4.
Liu, Zijian, et al.. (2021). An intelligent quantitative risk assessment method for ammonia synthesis process. Chemical Engineering Journal. 420. 129893–129893. 28 indexed citations
5.
Wang, Xin, Jingtao Zhong, Long-Tao Yue, et al.. (2018). Secretory Clusterin Mediates Oxaliplatin Resistance via the Gadd45a/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma. Journal of Cancer. 9(8). 1403–1413. 26 indexed citations
6.
Wei, Honglong, Zongzhen Xu, Feng Liu, et al.. (2017). Hypoxia induces oncogene yes-associated protein 1 nuclear translocation to promote pancreatic ductal adenocarcinoma invasion via epithelial–mesenchymal transition. Tumor Biology. 39(5). 3726130768–3726130768. 19 indexed citations
7.
8.
Li, Tao, Jingtao Zhong, Xiaofeng Dong, et al.. (2016). Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway. Oncology Reports. 35(6). 3614–3622. 28 indexed citations
9.
Wei, Honglong, Fuhai Wang, Yong Wang, et al.. (2016). Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the YAP‐TEAD complex. Cancer Science. 108(3). 478–487. 171 indexed citations
10.
Zhong, Jingtao, Peng Xiu, Xiaofeng Dong, et al.. (2015). Meloxicam combined with sorafenib synergistically inhibits tumor growth of human hepatocellular carcinoma cells via ER stress-related apoptosis. Oncology Reports. 34(4). 2142–2150. 15 indexed citations
11.
Zhong, Jingtao, Xiaofeng Dong, Peng Xiu, et al.. (2015). Blocking autophagy enhances meloxicam lethality to hepatocellular carcinoma by promotion of endoplasmic reticulum stress. Cell Proliferation. 48(6). 691–704. 22 indexed citations
12.
Wang, Fuhai, Xiaofeng Dong, Peng Xiu, et al.. (2014). T7 peptide inhibits angiogenesis via downregulation of angiopoietin-2 and autophagy. Oncology Reports. 33(2). 675–684. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jingtao Zhong Breakdown of academic impact, for papers by Jae Woo Jung Breakdown of academic impact, for papers by Sabrina Priam Breakdown of academic impact, for papers by Jin Gong Breakdown of academic impact, for papers by Jung Hwa Lim Breakdown of academic impact, for papers by Sarani Ghoshal Breakdown of academic impact, for papers by Tong Huang
Rankless by CCL
2026